Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-27T10:04:16.055Z Has data issue: false hasContentIssue false
  • English
  • Français

Take my breath away: a case of lactic acidosis in an asthma exacerbation

Published online by Cambridge University Press:  11 May 2015

Reid McGonigle  and
Robert A. Woods
Reid McGonigle*
Affiliation:
Île-à-la-Crosse Hospital, Île-à-la-Crosse, SK
Robert A. Woods
Affiliation:
Department of Surgery, College of Medicine, University of Saskatchewan, Saskatoon, SK
*
Île-à-la-Crosse Hospital, Île-à-la-Crosse, Sk SOM 1CO; reid.m@usask.ca

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A 36-year-old male with a history of chronic asthma presented to an emergency department with shortness of breath consistent with an asthma exacerbation. He had persistent tachypnea following inhaled bronchodilator treatment; thus, the workup and differential diagnosis were expanded. He was found to have a mixed respiratory alkalosis and metabolic acidosis with elevated serum lactate without an obvious cause and was admitted to hospital. His case was reviewed, and the lactic acidosis was thought to be caused by inhaled β2-agonist use. Emergency physicians should be aware of the potential side effects of inhaled β2-agonists as lactic acidosis may complicate clinical assessment and management of asthma exacerbations and lead to unnecessary and potentially dangerous escalations in therapy.

Keywords

asthmaβ2-agonistlactic acidosismetabolic acidosissalbutamol
Type
Case Report • Rapport de cas
Information
Canadian Journal of Emergency Medicine , Volume 13 , Issue 4 , July 2011 , pp. 284 - 288
Copyright
Copyright © Canadian Association of Emergency Physicians 2011

References

REFERENCES

1.Life and breath: respiratory disease in Canada. Ottawa (ON): Public Health Agency of Canada; 2007. Available at: http://www.phacaspc.gc.ca/publicat/2007/lbrdc-vsmrc/index-eng.php (accessed Oct 6, 2009).Google Scholar
2.Rowe, BH, Villa-Roel, C, Abu-Laban, RB, et al. Admission to Canadian hospitals for acute asthma: a prospective, multicenter study. Can Respir J 2010;17:25–30.CrossRefGoogle Scholar
3.Rowe, BH, Voaklander, DC, Wang, D, et al. Asthma presentations by adults to emergency departments in Alberta Canada: a large population-based study. Chest 2009;135:57–65.Google Scholar
4.Kaplan, AG, Balter, MS, Bell, AD, et al. Diagnosis of asthma in adults. CMAJ 2009. DOI: 10.1503/cmaj.080006.CrossRefGoogle ScholarPubMed
5.Chen, Y, Johansen, H, Thillaiampalam, S, et al. Asthma. Health Rep 2005;16(2):45–8.Google Scholar
6.Mountain, R, Heffner, J, Bracjett, N, et al. Acid-base disturbances in acute asthma. Chest 1990;98:651–5.Google Scholar
7.Manthous, CA. Lactic acidosis in status asthmaticus: three cases and review of the literature. Chest 2001;119:1599–602.Google Scholar
8.Braden, GL, Johnson, SS, Germain, MJ, et al. Lactic acidosis associated with the therapy of acute bronchospasm. N Engl J Med 1985;313:380.Google Scholar
9.Phillips, PJ, Vedig, AE, Jones, MG, et al. Metabolic and cardiovascular side effects of the beta-2 adrenoceptor agonists salbutamol and rimiterol. Br J Clin Pharmacol 1980;9:483–91.CrossRefGoogle ScholarPubMed
10.Maury, F, Ioos, V, Lepecq, B, et al. A paradoxical effect of bronchodilators. Chest 1997;111:1766–7.CrossRefGoogle ScholarPubMed
11.Meert, KL, Clark, J, Sarnaik, AP, et al. Metabolic acidosis as an underlying mechanism of respiratory distress in children with severe acute asthma. Pediatr Crit Care Med 2007;8:519–23.Google Scholar
12.Haffner, CA, Kendall, MJ. Metabolic effects of beta-2 agonists. J Clin Pharm Ther 1992;17:155–64.CrossRefGoogle ScholarPubMed
13.Rodrigo, GJ, Rodrigo, C. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma. Emerg Med J 2005;22:404–8.CrossRefGoogle ScholarPubMed
14.Prakash, S, Mehta, S. Lactic acidosis in asthma: report of two cases and review of the literature. Can Respir J 2002;9:203–8.Google Scholar
15.Gomez Bustos, MD, Garcia Ron, A, Ibarra de la Rosa, I, Pérez Navero, JL. Lactic acidosis following high-dose inhaled salbutamol. An Pediatr (Barc) 2008;69:586–7.Google Scholar
16.Gonzalez Jimenez, D, Concha Torre, A, Menendez Cuervo, S, García Hernández, I. Lactic acidosis secondary to inhaled salbutamol in children with acute severe asthma. An Pediatr (Barc) 2009;71:82–3.Google Scholar
17.Stratakos, G, Kolomenidis, J, Routsi, C, et al. Transient lactic acidosis as a side effect of inhaled salbutamol. Chest 2002;122:385–6.CrossRefGoogle ScholarPubMed
18.Creagh-Brown, B, Ball, J. An under-recognized complication of treatment of acute severe asthma. Am J Emerg Med 2008;26:514.e1-3.Google Scholar
19.Jee, R, Brownlow, H. Hyperlactaemia due to nebulised salbutamol. Anaesthesia 2007;62:744–55.CrossRefGoogle ScholarPubMed
20.Hodder, R, Lougheed, D, Rowe, BH, et al. Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ 2010;182:E55-67.CrossRefGoogle ScholarPubMed
21.Tobin, A. Intravenous salbutamol: too much of a good thing? Crit Care Resusc 2005;7:119–27.Google Scholar
22.Rivers, E, Nguyen, B, Havstad, S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368–77.Google Scholar